
|Articles|June 20, 2019
Proscia Launches AI-Powered Digital Pathology Solution
Advertisement
Proscia has released DermAI, a module on Proscia’s Concentriq Platform that leverages deep learning to pre-screen and classify skin biopsies. Proscia intends to submit DermAI to the FDA for review to use in clinical diagnosis.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Honing the Power of AI for Next Generation Trial Oversight and Execution
2
A Look Back: AI and Pragmatic Trials Took Center Stage at SCOPE Summit 2025
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
5